OBJECTIVEMetformin is the most common treatment for type 2 diabetes (T2D). However, there have been no pharmacogenomic...
Auteur - American Diabetes Association - Care
Age at Type 2 Diabetes Diagnosis and Cause-Specific Mortality:...
OBJECTIVETo examine the associations between age at type 2 diabetes diagnosis and the relative and absolute risk of all...
Point-of-Care Capillary Blood Ketone Measurements and the Prediction...
OBJECTIVERather than during illness while diabetic ketoacidosis (DKA) is developing, we aimed to determine if levels of...
Fully Closed-Loop Glucose Control Compared With Insulin Pump Therapy...
OBJECTIVEWe evaluated the safety and efficacy of fully closed-loop with ultrarapid insulin lispro in adults with type 1...
Glucose Monitoring Metrics in Individuals With Type 1 Diabetes Using...
OBJECTIVEThis study aimed to investigate the association between continuous glucose monitoring (CGM)-derived glycemic...
Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That...
OBJECTIVEIn November 2022, teplizumab-mzwv became the first drug approved to delay the onset of stage 3 type 1 diabetes in...
Gastrointestinal Infections Modulate the Risk for Insulin...
OBJECTIVETo investigate gastrointestinal infection episodes (GIEs) in relation to the appearance of islet autoantibodies in...
Change in the Relation Between Age and Cardiovascular Events Among...
This study was funded internally through an agreement between ICES and Women’s College Hospital.
Erratum. Remnant Cholesterol Is an Independent Predictor of Type 2...
In Table 2 of the article cited above, there were typographical errors in the presentation of triglycerides and non-HDL...
Erratum. The Incidence of Adult-Onset Type 1 Diabetes: A Systematic...
In the article cited above, author Ronald C.W. Ma was inadvertently omitted as a corresponding author.